FeesSafety
Pluang+

RenovoRx appoints medtech leader Richard Stark to its Board to boost commercialization of cancer drug-delivery device.

Company Fundamentals
19 Nov 2026, 15:30 WIB
GlobeNewsWire
View Source
Bullish
RenovoRx appoints medtech leader Richard Stark to its Board to boost commercialization of cancer drug-delivery device.

RenovoRx, a life sciences company commercializing the FDA-cleared RenovoCath drug-delivery device, appointed Richard A. Stark, CEO of Innoblative Designs, to its Board of Directors. Stark brings over 30 years of experience in interventional oncology medtech and has advised RenovoRx since 2024, helping shape its commercial strategy. His addition aims to accelerate physician adoption and market penetration of RenovoCath and the TAMP platform across U.S. cancer centers. RenovoRx is also advancing a Phase III trial for its drug-device combo targeting pancreatic cancer, with topline data expected in late 2027.

RenovoRx's board appointment news is presented here with relevant Health-sector market data from Pluang. For readers following Health-sector stocks, 82 of 150 priced US stocks rose and 63 fell today. Notable movers include TWST at USD 120.44 (+3.52%), NUWE at USD 3.95 (+3.13%), and BIO at USD 358.60 (-3.13%). This data is as of Nov 19, 2026 19:13 WIB.

More News

Philips launches Advanced Image Insights, a cloud AI tool to streamline radiology workflows and reporting.

Philips launches Advanced Image Insights, a cloud AI tool to streamline radiology workflows and reporting.

Philips introduced Advanced Image Insights, a cloud-based solution that integrates advanced visualization and AI applications into radiology workflows. This platform connects image analysis with interactive reporting, helping radiologists manage comp...

Market News
Bullish
50 minutes ago
Bojangles boosts promotional menu capacity 8X and cuts shortages by 1,000 weekly with Armada's supply chain platform

Bojangles boosts promotional menu capacity 8X and cuts shortages by 1,000 weekly with Armada's supply chain platform

Bojangles expanded its limited-time offers from 3 to 26 per year using Armada's PRO platform, improving supply chain visibility and coordination without adding staff. This led to a reduction of 1,000 weekly shortages and nearly perfect fill rates dur...

Market News
Bullish
50 minutes ago
Disney shows stronger stability and upside than Nvidia despite both being cheap stocks.

Disney shows stronger stability and upside than Nvidia despite both being cheap stocks.

Disney and Nvidia both reported solid quarterly results and trade at about 16 times this year's earnings, making them historically cheap. Disney's stock is up 8% this year with a smooth CEO transition, while Nvidia's stock has slid 19% amid CEO scand...

Market News
Neutral
1 hour ago
Financial sector ETF XLF underperforms despite rising rates; history suggests potential for gains ahead.

Financial sector ETF XLF underperforms despite rising rates; history suggests potential for gains ahead.

The State Street Financial Select Sector SPDR ETF (XLF), a major financial sector fund, has underperformed this year despite a rising interest rate environment that typically benefits financial stocks. With the Federal Reserve expected to raise rates...

Bullish
1 hour ago
Bloom Energy posts strong Q3 growth but stock drops amid AI spending uncertainty

Bloom Energy posts strong Q3 growth but stock drops amid AI spending uncertainty

Bloom Energy reported a robust third quarter with revenue up 138% year-over-year to $1.24 billion and operating income rising sharply to $225 million. Despite this growth and improved profitability, the stock has fallen over 40% from its highs due to...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App